These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 4729899

  • 1. Elimination of tritiated gentamicin in normal human subjects and in patients with severely impaired renal function.
    Wilson TW, Mahon WA, Inaba T, Johnson GE, Kadar D.
    Clin Pharmacol Ther; 1973; 14(5):815-22. PubMed ID: 4729899
    [No Abstract] [Full Text] [Related]

  • 2. Gentamicin pharmacokinetics during hemodialysis in patients suffering from chronic renal failure.
    Létourneau-Saheb L, Lapierre L, Daigneault R, Prud'Homme M, St-Louis G, Serois G.
    Int J Clin Pharmacol Biopharm; 1977 Mar; 15(3):116-20. PubMed ID: 844930
    [Abstract] [Full Text] [Related]

  • 3. [Pharmacokinetics of gentamycin sulfate in the healthy and in patients with terminal renal failure].
    Dume T, Wetzels E, Herms W, Schröder E, Wahlig H.
    Dtsch Med Wochenschr; 1971 Apr 23; 96(17):734-8 passim. PubMed ID: 4994837
    [No Abstract] [Full Text] [Related]

  • 4. Pharmacokinetic analysis of gentamicin dosage regimens recommended for renal impairment.
    Schumacher GE.
    J Clin Pharmacol; 1975 Oct 23; 15(10):656-65. PubMed ID: 1184769
    [No Abstract] [Full Text] [Related]

  • 5. The elimination of tritiated doxycycline in normal subjects and in patients with severely impaired renal function.
    Mahon WA, Johnson GE, Endrenyl L, Kelly MF, Fenton SS.
    Scand J Infect Dis Suppl; 1976 Oct 23; (9):24-31. PubMed ID: 1070145
    [Abstract] [Full Text] [Related]

  • 6. Gentamicin therapy in renal failure: a nomogram for dosage.
    Chan RA, Benner EJ, Hoeprich PD.
    Ann Intern Med; 1972 May 23; 76(5):773-8. PubMed ID: 4623584
    [No Abstract] [Full Text] [Related]

  • 7. [Is endogenous creatinine clearance a sound basis for estimation of elimination half life of gentamicin?].
    Rameis H, Hitzenberger G, Jaschek I, Graninger W.
    Dtsch Med Wochenschr; 1980 Nov 21; 105(47):1650-4. PubMed ID: 7439047
    [Abstract] [Full Text] [Related]

  • 8. Changes in the apparent half life of gentamicin and tobramycin without detectable changes in creatinine clearance.
    Vozeh S, Spring P, Wenk M, Follath F.
    Br J Clin Pharmacol; 1979 Jun 21; 7(6):629-31. PubMed ID: 465287
    [No Abstract] [Full Text] [Related]

  • 9. Disposition of digitoxin in renal failure.
    Vöhringer HF, Rietbrock N, Spurny P, Kuhlmann J, Hampl H, Baethke R.
    Clin Pharmacol Ther; 1976 Apr 21; 19(4):387-95. PubMed ID: 1269191
    [Abstract] [Full Text] [Related]

  • 10. Pharmacokinetics of netilmicin in the presence of normal or impaired renal function.
    Humbert G, Leroy A, Fillastre JP, Oksenhendler G.
    Antimicrob Agents Chemother; 1978 Jul 21; 14(1):40-4. PubMed ID: 686708
    [Abstract] [Full Text] [Related]

  • 11. Pharmacokinetics of netilmicin in patients with renal impairment and in patients on dialysis.
    Luft FC, Brannon DR, Stropes LL, Costello RJ, Sloan RS, Maxwell DR.
    Antimicrob Agents Chemother; 1978 Sep 21; 14(3):403-7. PubMed ID: 708018
    [Abstract] [Full Text] [Related]

  • 12. Pharmacokinetics of netilmicin in renal insufficiency and haemodialysis.
    Pechere JC, Dugal R, Pechere MM.
    Clin Pharmacokinet; 1978 Sep 21; 3(5):395-406. PubMed ID: 699461
    [Abstract] [Full Text] [Related]

  • 13. Flucytosine kinetics in subjects with normal and impaired renal function.
    Cutler RE, Blair AD, Kelly MR.
    Clin Pharmacol Ther; 1978 Sep 21; 24(3):333-42. PubMed ID: 688726
    [No Abstract] [Full Text] [Related]

  • 14. Effect of ticarcillin on gentamicin and tobramycin pharmacokinetics in a patient with end-stage renal disease.
    Matzke GR, Luckham DR, Collins AJ, Halstenson CE.
    Pharmacotherapy; 1984 Sep 21; 4(3):158-60. PubMed ID: 6739313
    [No Abstract] [Full Text] [Related]

  • 15. [Use of analog computer for the study of gentamicin pharmacokinetics in persons with normal or reduced kidney function].
    Modr Z, Dvorácek K, Schmidt O.
    Cas Lek Cesk; 1974 Sep 20; 113(38):1163-8. PubMed ID: 4417189
    [No Abstract] [Full Text] [Related]

  • 16. Gentamicin persistence in the body.
    Schentag JJ, Jusko WJ.
    Lancet; 1977 Feb 26; 1(8009):486. PubMed ID: 65590
    [No Abstract] [Full Text] [Related]

  • 17. [Gentamicin treatment in nondialized, hemodialyzed and peritoneal-dialyzed renal patients].
    El Matri A, Meknini A, Ben Ayed H.
    Tunis Med; 1977 Feb 26; 55(5):297-305. PubMed ID: 611654
    [No Abstract] [Full Text] [Related]

  • 18. Preliminary studies on the elimination of 3-H doxycycline in normal subjects and in patients with severely impaired renal function.
    Mahon WA, Johnson GE, Kelly MF, Fenton SS.
    Rev Can Biol; 1973 Feb 26; 32():Suppl:107-11. PubMed ID: 4777591
    [No Abstract] [Full Text] [Related]

  • 19. Gentamicin disposition in children with chronic renal failure.
    Berry PL, Kearns GL, Brown RD, Ritschel WA, Thompson GA, McEnery PT.
    Pediatr Pharmacol (New York); 1982 Feb 26; 2(4):257-73. PubMed ID: 6927126
    [Abstract] [Full Text] [Related]

  • 20. Estimation of drug elimination in renal failure.
    Perrier D, Gibaldi M.
    J Clin Pharmacol; 1973 Feb 26; 13(11):458-62. PubMed ID: 4490668
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.